MedTrace Logo

Ovarian Tumor Biopsies to Study Response to Treatments

NCT02952521 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2022-05-10

No results posted yet for this study

Summary

This is a research study to look at differences in tumor tissue from ovarian cancer patients that may help to determine response and resistance to treatments.

Conditions

  • Epithelial Ovarian Cancer

Interventions

PROCEDURE

Blood Draw

CA125 and ctDNA

PROCEDURE

Tumor Tissue Biopsy

Only collected at time of surgery if patient undergoes surgical debulking

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Amit Oza, M.D. · Princess Margaret Cancer Centre

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-25
Primary Completion
2021-10-28
Completion
2021-10-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02952521 on ClinicalTrials.gov